Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Sep 18, 2017
SEATTLE, Sept. 18, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has demonstrated the capability of its Hyb & Seq technology to perform liquid biopsy measurement.  The proof-of-principle work was ...
Sep 7, 2017
SEATTLE, Sept. 07, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Morgan Stanley Global Healthcare Conference in New York City, on Tuesday, September 12, ...
Sep 5, 2017
SEATTLE, Sept. 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Anthem has issued a positive coverage decision for the Prosigna® Breast Cancer Gene Signature Assay.  This positive coverage decision is i...
Aug 31, 2017
SEATTLE, Aug. 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Baird Global Healthcare Conference in New York City, on Thursday, September 7, 2017. ...
Aug 8, 2017
SEATTLE, Aug. 08, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2017.  Second Quarter Financial Highlights  Total revenue of $34.6 million, 53% year-over-year growt...
Aug 8, 2017
SEATTLE and FREMONT, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Lam Research Corporation (Nasdaq:LRCX), a global supplier of innovative wafer fabrication equipment and services to the semiconductor industr...
Jul 10, 2017
SEATTLE, July 10, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2017 financial results after the close of trading on Tuesday, August 8, 2017. Company management will ho...
Jul 5, 2017
SEATTLE, July 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that J. Chad Brown has been appointed Senior Vice President of Sales and Marketing, effective July 5, 2017.    Mr. Brown is a senior healthcare ...
Jun 6, 2017
SEATTLE, June 06, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock at a price of $16.75 per share, which in...
Jun 1, 2017
SEATTLE, June 01, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a price of $16.75 per share pursuant to its existing shelf ...
May 31, 2017
SEATTLE, May 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an agreement to sell 2,750,000 shares of its common stock to Robert W. Baird & Co. Incorporated as the underwriter in an underwritten public offering ...
May 30, 2017
SEATTLE, May 30, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Jefferies Healthcare Conference in New York City, on Wednesday, June 7, 2017. The web...
May 25, 2017
More than 35 Abstracts Demonstrate the Value of the nCounter Platform for Targeted Discovery, Biomarker Development and Diagnostic Applications in Cancer Research and Immuno-Oncology NanoString's New Digital Spatial Profiling Technology Featured in Two Abstracts SEATTLE, May 25, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ...
May 10, 2017
SEATTLE, May 10, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Elisha W. Finney, former executive vice president and chief financial officer at Varian Medical Systems (NYSE: VAR), to its Board o...
May 4, 2017
SEATTLE, May 04, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2017. First Quarter Financial Highlights Total revenue of $18.1 million, 23% year-over-year growthTota...
Page:
...
Next Last
 
= add release to Briefcase